Advertisement
UK markets open in 3 hours 28 minutes
  • NIKKEI 225

    38,189.54
    -216.12 (-0.56%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • CRUDE OIL

    81.14
    -0.79 (-0.96%)
     
  • GOLD FUTURES

    2,296.00
    -6.90 (-0.30%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • Bitcoin GBP

    48,062.10
    -2,999.86 (-5.87%)
     
  • CMC Crypto 200

    1,284.87
    -54.20 (-4.05%)
     
  • NASDAQ Composite

    15,657.82
    -325.26 (-2.04%)
     
  • UK FTSE All Share

    4,430.25
    -4.93 (-0.11%)
     

Here's What Key Metrics Tell Us About Travelers (TRV) Q1 Earnings

Travelers (TRV) reported $11.19 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 15.4%. EPS of $4.69 for the same period compares to $4.11 a year ago.

The reported revenue represents a surprise of +0.05% over the Zacks Consensus Estimate of $11.19 billion. With the consensus EPS estimate being $4.75, the EPS surprise was -1.26%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Travelers performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Combined Ratio - Consolidated: 93.9% versus the nine-analyst average estimate of 93.9%.

  • Loss and loss adjustment expense ratio - Consolidated: 65.2% versus the nine-analyst average estimate of 65.3%.

  • Underwriting Expense Ratio - Consolidated: 28.7% versus 28.6% estimated by nine analysts on average.

  • Combined Ratio - Bond & Specialty Insurance: 84.5% compared to the 81.3% average estimate based on eight analysts.

  • Total Revenues- Other Revenues: $112 million versus $84.87 million estimated by 10 analysts on average. Compared to the year-ago quarter, this number represents a +49.3% change.

  • Total Revenues- Net investment income: $846 million versus the 10-analyst average estimate of $807.55 million. The reported number represents a year-over-year change of +27.6%.

  • Total Revenues- Premiums: $10.13 billion versus the 10-analyst average estimate of $10.18 billion. The reported number represents a year-over-year change of +14.4%.

  • Total Revenues- Fee income: $109 million versus the nine-analyst average estimate of $110.87 million. The reported number represents a year-over-year change of +2.8%.

  • Revenues- Premiums- Bond & Specialty Insurance: $956 million compared to the $966.97 million average estimate based on seven analysts. The reported number represents a change of +9.3% year over year.

  • Revenues- Premiums- Personal Insurance: $4.01 billion versus the seven-analyst average estimate of $4.02 billion. The reported number represents a year-over-year change of +14.5%.

  • Revenues- Premiums- Business Insurance: $5.16 billion versus $5.16 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +15.3% change.

  • Revenues- Fee income- Business Insurance: $101 million versus $103.80 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +2% change.

View all Key Company Metrics for Travelers here>>>

Shares of Travelers have returned -0.2% over the past month versus the Zacks S&P 500 composite's -1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research